Added Benefit of Immature Oocyte Maturation for Fertility Preservation in Women with Malignancy
Authors:
- 2 July 2020
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 27 (12) , 2257-2264
Abstract
To assess the added value of maturing immature oocytes collected during fertility preservation treatments in women with malignancy. A retrospective case-control study analyzing the results of 327 cancer patients undergoing fertility preservation treatments. Oocyte maturation rates and cycle parameters were compared between 3 types of fertility preservation treatments: (1) stimulated IVF cycle (n = 143), (2) non-stimulated IVM cycle (n = 158), (3) follicle aspiration and oocyte collection from ovarian tissue prepared for ovarian tissue cryopreservation followed by in vitro maturation of the immature oocytes (n = 48). The primary outcome measure was the maturation rate and the number of mature oocytes. The secondary outcomes were oocyte fertilization and embryo development rates. The mean maturation rate in IVF cycles was 38% and in the non-stimulated IVM cycles was 55%. In women who chose to cryopreserve their embryos, similar fertilization and embryo cleavage rates were found in oocytes that matured after stimulated IVF cycles compared to non-stimulated IVM cycles. Gonadotropin-releasing hormone agonist triggering, treatment with aromatase inhibitor, or oral contraceptives use before the cycle did not affect the maturation rate. Ovarian stimulation yields the highest number of oocytes or embryos for cryopreservation. Although the maturation rate of immature oocytes collected in stimulated IVF cycles is low, it is still a viable source of oocytes that can be used to improve the efficacy of fertility preservation treatments by increasing the number of mature oocytes available for freezing or fertilization.Keywords
This publication has 35 references indexed in Scilit:
- Fertility Preservation in WomenNew England Journal of Medicine, 2017
- The total pregnancy potential per oocyte aspiration after assisted reproduction—in how many cycles are biologically competent oocytes available?Journal of Assisted Reproduction and Genetics, 2016
- Oocyte vitrification as an efficient option for elective fertility preservationFertility and Sterility, 2016
- Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rateFertility and Sterility, 2015
- Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancerReproductive BioMedicine Online, 2014
- Fertility preservation in women with cancerThe Lancet, 2014
- Effective method for emergency fertility preservation: random-start controlled ovarian stimulationFertility and Sterility, 2013
- From oocyte to baby: a clinical evaluation of the biological efficiency of in vitro fertilizationFertility and Sterility, 2009
- Fertilization, embryo development, and clinical outcome of immature oocytes from stimulated intracytoplasmic sperm injection cyclesFertility and Sterility, 2007
- In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injectionHuman Reproduction, 1999